CLINICAL VIROLOGY NETWORK
The aim of the network is to promote the interests of clinical virology, and its medical and laboratory practise in the United Kingdom and Ireland.The Network provides evidence -based and practical virological advice to Government , Chief Medical Officers, the National Health Service and Public Health England on all aspects of viral diseases.
Objects
THE CHARITY’S OBJECTS (‘OBJECTS’) ARE SPECIFICALLY RESTRICTED TO THE FOLLOWING:FOR THE PUBLIC BENEFIT TO RELIEVE SICKNESS, PROMOTE GOOD HEALTH AND TO ADVANCE EDUCATION IN THE SUBJECT OF VIROLOGY, IN PARTICULAR BUT NOT EXCLUSIVELY BY:1.PROMOTING CLINICAL VIROLOGY AND ITS MEDICAL AND LABORATORY PRACTICE IN THE UNITED KINGDOM AND NORTHERN IRELAND;2.PROMOTING HIGH STANDARDS IN LABORATORY VIRAL DIAGNOSIS THROUGH QUALITY ASSESSMENT ACTIVITIES AND EDUCATION ;3.IMPROVING AND SHARING THE KNOWLEDGE OF VIRUSES, PARTICULARLY AS IT RELATES TO THE DIAGNOSIS AND MANAGEMENT OF VIRAL DISEASES, THEIR PATHOGENESIS, NATURAL HISTORY AND PREVENTION; 4.IMPROVING AND SHARING DIAGNOSTIC METHODS.
Financial health, per its FY2025 accounts
The accounts state that the charity incurred a net expenditure of £5,294 in the year ended 31 May 2025, resulting in a decrease in total unrestricted funds from £166,157 to £160,863. Per the trustees' report, the charity maintains sufficient cash reserves of £135,702 to meet its current liabilities and ongoing operations.
What the accounts disclose
Policies the charity declares
- Paying staff
- Risk management
- Safeguarding vulnerable beneficiaries
From the charity’s annual return (Part A, self-declared)
Self-declared on the annual return for the financial year ending 31/05/2025
- Volunteers: 10
- Grant-making is its main activity
Annual return filing dates (Charity Commission record)
Of its last 5 annual returns with a recorded received date, 3 were received after the due date: year ending 31/05/2023 (received 18/03/2025, 352 days after the 31/03/2024 due date); year ending 31/05/2022 (received 26/06/2023, 87 days after the 31/03/2023 due date); year ending 31/05/2021 (received 21/06/2022, 82 days after the 31/03/2022 due date).
Trustees
- Dr MARK ZUCKERMAN
- WILLIAM IRVING
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/05/2025 | £50k | £55k |
| 31/05/2024 | £62k | £50k |
| 31/05/2023 | £71k | £31k |
| 31/05/2022 | £42k | £35k |
| 31/05/2021 | £38k | £17k |
Common questions
Is CLINICAL VIROLOGY NETWORK financially healthy?
Per its FY2025 accounts: The accounts state that the charity incurred a net expenditure of £5,294 in the year ended 31 May 2025, resulting in a decrease in total unrestricted funds from £166,157 to £160,863. Per the trustees' report, the charity maintains sufficient cash reserves of £135,702 to meet its current liabilities and ongoing operations. Its FY2025 accounts were independently examined.
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| THE ROGER RAYMOND CHARITABLE TRUST | 1 | £151k |
| ROBERT LUFF FOUNDATION LIMITED | 1 | £103k |
| THE BALCOMBE CHARITABLE TRUST | 1 | £89k |
| THE REED FOUNDATION | 1 | £56k |
| BANHAM FOUNDATION LIMITED | 1 | £25k |
| PILKINGTON CHARITIES FUND | 1 | £20k |
| THE HENRY LUMLEY CHARITABLE TRUST | 1 | £20k |
| THE GRAND LODGE OF MARK MASTER MASONS' FUND OF BENEVOLENCE | 1 | £16k |
Charities like this
- EUROPEAN SOCIETY FOR CLINICAL VIROLOGY
- NETWORK FOR IMPROVING CRITICAL-CARE SYSTEMS AND TRAINING
- THE VASCULAR SOCIETY
- THE SCIENTIFIC AND MEDICAL NETWORK
- Liver UK
- THE CLINICAL GENETICS SOCIETY
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| CLINICAL VIROLOGY NETWORK | £50k | — | 0 | unclear | — | no doubt |
| EUROPEAN SOCIETY FOR CLINICAL VIROLOGY | £62k | — | 0 | unclear | — | no doubt |
| NETWORK FOR IMPROVING CRITICAL-CARE SYSTEMS AND TRAINING | £100k | — | 0 | unclear | — | no doubt |
| THE VASCULAR SOCIETY | £590k | — | 0 | unclear | — | no doubt |
| THE SCIENTIFIC AND MEDICAL NETWORK | £451k | — | 0 | above | — | no doubt |
| Liver UK | £2.5m | — | 2 | within | 23.8% | no doubt |